Showing 1 - 10 of 19
This paper attempts to quantify the private and public economic value of reducing obesity through pharmaceutical and medical interventions. We find that the economic value of such treatments, in particular bariatric surgery, is large for treated patients, with incremental cost-effectiveness...
Persistent link: https://www.econbiz.de/10008865976
We propose to combine clinical trial and estimates of behavioral responses in the population to quantify the value of new drug innovations when such values cannot be obtained by randomized experiments alone. New drugs are seen as having two distinct effects on patients. First, they can provide...
Persistent link: https://www.econbiz.de/10008646239
This paper uses comparable micro-data from over 15 OECD countries to study the causal relationship between education and health outcomes. We combine three surveys (SHARE, HRS and ELSA) that include nationally representative samples of people aged 50 and over in these countries. We use variation...
Persistent link: https://www.econbiz.de/10010693197
It is now well recognized that all types of regulation are imposing costs on our society. The studies which have tried to evaluate these costs are numerous and their methologies are diversified. This paper is proposing a critical analysis of these methodologies and of the results obtained by...
Persistent link: https://www.econbiz.de/10005489851
In this paper, we compare individual survival curves constructed from objective (actual mortality) and elicited subjective information (probability of survival to a given target age). We develop a methodology to estimate jointly subjective and objective individual- survival curves accounting for...
Persistent link: https://www.econbiz.de/10011093878
The effect of job loss on health may play an important role in the development of the SES-health gradient. In this paper, we estimate the effect of job loss on objective measures of physiological dysregulation using longitudinal data from the Health and Re- tirement Study and biomarker measures...
Persistent link: https://www.econbiz.de/10011093879
Nous nous intéressons au risque futur de longévité étant donné l'augmentation de l'espérance de vie due au progrès technologique et la hausse de la prévalence de maladies liées à l'obésité et à la sédentarité. Nous utilisons dans un premier temps des techniques de microsimulation...
Persistent link: https://www.econbiz.de/10011093880
We use simulation methods to analyze the impacts of certain proposed reforms to improve the coverage of longevity risk. This risk, which may in principle be adequately covered by classic defined-benefit pension plans, has been of particular interest in Quebec for some years now, notably due to...
Persistent link: https://www.econbiz.de/10011115739
Nous présentons dans ce document la conception et la structure de COMPAS, un modèle de microsimulation dynamique portant sur l’état et l’utilisation de soins de santé des Québécois. Ce modèle comporte deux dimensions importantes : un composante dynamique, qui permet une évo- lution...
Persistent link: https://www.econbiz.de/10011115740
Nous utilisons des méthodes de simulation pour analyser les impacts de certaines propo- sitions de réforme visant à améliorer la couverture du risque de longévité. Ce risque, qui peut en principe être adéquatement couvert par les régimes de retraite classiques à prestations...
Persistent link: https://www.econbiz.de/10011115742